EMBL Ventures is an independent venture capital investor that manages two Funds with a total of €68 million capital on behalf of major European institutional and private investors. EMBL Ventures' close relationship with the European Molecular Biology Laboratory (EMBL) and its technology transfer organization EMBL Enterprise Management Technology Transfer GmbH (EMBLEM) allows it to finance disruptive technologies in an entrepreneurial start-up environment, aiming ultimately for a transaction with a partner that is seeking to acquire external product innovation. EMBL Ventures is exclusively focused on life-science investments.

"Moving a project from a research lab to a company is a daunting process. When the ideas we generated in the lab warranted the establishment of Elara Pharmaceuticals, the task of converting an idea into a commercial entity was greatly helped by EMBL Ventures. Every step of the process has been guided by their expertise. Their task is a delicate one as they have to understand the mentality of the founders and the funders and to achieve benefits for both sides. From our experience with Elara Pharmaceuticals, EMBL Ventures succeeded exceptionally well in achieving our mutual goals."
Prof. Frank Gannon, PhD; Science Foundation Ireland, former Director of EMBO and co-founder of Elara Pharmaceuticals